6533b835fe1ef96bd12a0163
RESEARCH PRODUCT
Improved Expression of His6-Tagged Strictosidine Synthase cDNA for Chemo-Enzymatic Alkaloid Diversification
Joachim StöckigtJoachim StöckigtMartin RuppertHuajian ZhuHongbin ZouHongbin ZouLiuqing YangJingxu Gongsubject
TryptamineStrictosidine synthaseCatharanthusStereochemistryRecombinant Fusion ProteinsIridoid GlucosidesBioengineeringBiochemistryEnzyme catalysischemistry.chemical_compoundAlkaloidsBiosynthesisCarbon-Nitrogen LyasesHistidineIridoidsVinca AlkaloidsMolecular Biologychemistry.chemical_classificationbiologyGeneral ChemistryGeneral MedicineTryptaminesEnzymechemistryBiochemistryChaperone (protein)StrictosidineBiocatalysisbiology.proteinMolecular MedicineSecologaninOligopeptidesMolecular Chaperonesdescription
Strictosidine synthase (STR1) catalyzes the stereoselective formation of 3alpha(S)-strictosidine from tryptamine and secologanin. Strictosidine is the key intermediate in the biosynthesis of 2,000 plant monoterpenoid indole alkaloids, and it is a key precursor of enzyme-mediated synthesis of alkaloids. An improved expression system is described which leads to optimized His(6)-STR1 synthesis in Escherichia coli. Optimal production of STR1 was achieved by determining the impact of co-expression of chaperones pG-Tf2 and pG-LJE8. The amount and activity of STR1 was doubled in the presence of chaperone pG-Tf2 alone. His(6)-STR1 immobilized on Ni-NTA can be used for enzymatic synthesis of strictosidines on a preparative scale. With the newly co-expressed His(6)-STR1, novel 3alpha(S)-12-azastrictosidine was obtained by enzymatic catalysis of 7-azatryptamine and secologanin. The results obtained are of significant importance for application to chemo-enzymatic approaches leading to diversification of alkaloids with novel improved structures.
year | journal | country | edition | language |
---|---|---|---|---|
2010-04-01 | Chemistry & Biodiversity |